Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Insulinlike Growth Factor-Binding Protein-1 Improves Vascular Endothelial Repair in Male Mice in the Setting of Insulin Resistance.

Endocrinology | 2018

Insulin resistance is associated with impaired endothelial regeneration in response to mechanical injury. We recently demonstrated that insulinlike growth factor-binding protein-1 (IGFBP1) ameliorated insulin resistance and increased nitric oxide generation in the endothelium. In this study, we hypothesized that IGFBP1 would improve endothelial regeneration and restore endothelial reparative functions in the setting of insulin resistance. In male mice heterozygous for deletion of insulin receptors, endothelial regeneration after femoral artery wire injury was enhanced by transgenic expression of human IGFBP1 (hIGFBP1). This was not explained by altered abundance of circulating myeloid angiogenic cells. Incubation of human endothelial cells with hIGFBP1 increased integrin expression and enhanced their ability to adhere to and repopulate denuded human saphenous vein ex vivo. In vitro, induction of insulin resistance by tumor necrosis factor α (TNFα) significantly inhibited endothelial cell migration and proliferation. Coincubation with hIGFBP1 restored endothelial migratory and proliferative capacity. At the molecular level, hIGFBP1 induced phosphorylation of focal adhesion kinase, activated RhoA and modulated TNFα-induced actin fiber anisotropy. Collectively, the effects of hIGFBP1 on endothelial cell responses and acceleration of endothelial regeneration in mice indicate that manipulating IGFBP1 could be exploited as a putative strategy to improve endothelial repair in the setting of insulin resistance.

Pubmed ID: 29186427 RIS Download

Associated grants

  • Agency: British Heart Foundation, United Kingdom
    Id: CH/13/1/30086
  • Agency: British Heart Foundation, United Kingdom
    Id: RG/15/7/31521
  • Agency: British Heart Foundation, United Kingdom
    Id: FS/12/51/29584
  • Agency: British Heart Foundation, United Kingdom
    Id: FS/11/44/28820
  • Agency: British Heart Foundation, United Kingdom
    Id: FS/11/73/29014
  • Agency: British Heart Foundation, United Kingdom
    Id: FS/11/94/29180
  • Agency: British Heart Foundation, United Kingdom
    Id: FS/12/80/29821

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Anti-β-Actin Antibody (C4) (antibody)

RRID:AB_626632

This monoclonal targets β-Actin

View all literature mentions

Phospho-FAK (Tyr397) (D20B1) Rabbit mAb (antibody)

RRID:AB_10891442

This monoclonal targets Phospho-FAK (Tyr397) (D20B1) Rabbit mAb

View all literature mentions

FAK Antibody (antibody)

RRID:AB_2269034

This polyclonal targets Ptk2

View all literature mentions

Phospho-Akt (Ser473) (D9E) XP® Rabbit mAb (antibody)

RRID:AB_2315049

This monoclonal targets Phospho-Akt (Ser473)

View all literature mentions

Akt Antibody (antibody)

RRID:AB_329827

This polyclonal targets Akt

View all literature mentions

Rat IgG2a Clone: R35-95, R-Phycoerythrin Conjugated/Tagged (antibody)

RRID:AB_479719

This unknown targets Rat IgG2a Clone: R35-95 R-Phycoerythrin /Tagged

View all literature mentions

Flk-1 (antibody)

RRID:AB_2034023

This monoclonal targets Flk-1

View all literature mentions

Rat IgG2a, k (antibody)

RRID:AB_395144

This monoclonal targets Rat IgG2a k

View all literature mentions